Carotid body tumor epidemiology and demographics

	Carotid body tumor Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Carotid Body Tumor from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Carotid body tumor epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Carotid body tumor epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Carotid body tumor epidemiology and demographics
CDC on Carotid body tumor epidemiology and demographics
Carotid body tumor epidemiology and demographics in the news
Blogs on Carotid body tumor epidemiology and demographics
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Carotid body tumor epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Overview

The prevalence of carotid body tumor is approximately 65% of head and neck paraganglioma.^[2]
The prevalence of head and neck paraganglioma is 3% of all paraganglioma.
The estimated prevalence of parasymapathetic paraganglioma is approximately 1-2 cases per 100,000 individuals worldwide.

In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Carotid body tumor is more commonly observed in the adults and particularly in their fifth decade of life.^[3]
In familial cases, the mean age of onset is younger, being the second or fourth decade of life.^[4]

There is no gender preference in the incidence of this tumor according to the recent literature.^[4]

↑ Wieneke, Jacqueline A.; Smith, Alice (2009). "Paraganglioma: Carotid Body Tumor". Head and Neck Pathology. 3 (4): 303–306. doi:10.1007/s12105-009-0130-5. ISSN 1936-055X.
↑ Xiao, Zebin; She, Dejun; Cao, Dairong (2015). "Multiple paragangliomas of head and neck associated with hepatic paraganglioma: a case report". BMC Medical Imaging. 15 (1). doi:10.1186/s12880-015-0082-z. ISSN 1471-2342.
↑ Lee, Ki Yeol; Oh, Yu-Whan; Noh, Hyung Jun; Lee, Yu Jin; Yong, Hwan-Seok; Kang, Eun-Young; Kim, Kyeong Ah; Lee, Nam Joon (2006). "Extraadrenal Paragangliomas of the Body: Imaging Features". American Journal of Roentgenology. 187 (2): 492–504. doi:10.2214/AJR.05.0370. ISSN 0361-803X.
↑ ^4.0 ^4.1 Burgess, Alfred; Calderon, Moises; Jafif-Cojab, Marcos; Jorge, Diego; Balanza, Ricardo (2017). "Bilateral carotid body tumor resection in a female patient". International Journal of Surgery Case Reports. 41: 387–391. doi:10.1016/j.ijscr.2017.11.019. ISSN 2210-2612.